Susquehanna International Group
GBT

Susquehanna International Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Susquehanna International Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-235,800
Closed -$16.1M – 14655
2022
Q3 		$16.1M Buy
235,800
+125,200
+113% +$6.9M ﹤0.01% 1624
2022
Q2 		$3.53M Buy
110,600
+23,200
+27% +$679K ﹤0.01% 3787
2022
Q1 		$3.03M Buy
87,400
+26,700
+44% +$798K ﹤0.01% 4599
2021
Q4 		$1.78M Sell
60,700
-30,000
-33% -$929K ﹤0.01% 5788
2021
Q3 		$2.31M Buy
90,700
+49,500
+120% +$1.45M ﹤0.01% 5529
2021
Q2 		$1.44M Sell
41,200
-44,500
-52% -$1.74M ﹤0.01% 6755
2021
Q1 		$3.49M Sell
85,700
-72,400
-46% -$3.33M ﹤0.01% 4642
2020
Q4 		$6.85M Buy
158,100
+55,200
+54% +$2.72M ﹤0.01% 2970
2020
Q3 		$5.67M Sell
102,900
-71,600
-41% -$4.55M ﹤0.01% 2892
2020
Q2 		$11M Sell
174,500
-19,000
-10% -$1.3M ﹤0.01% 2030
2020
Q1 		$9.89M Sell
193,500
-247,000
-56% -$16.5M ﹤0.01% 1752
2019
Q4 		$35M Buy
440,500
+254,900
+137% +$15.1M 0.01% 1021
2019
Q3 		$9.01M Sell
185,600
-140,200
-43% -$7.31M ﹤0.01% 2093
2019
Q2 		$17.1M Sell
325,800
-116,800
-26% -$6.71M 0.01% 1396
2019
Q1 		$23.4M Buy
442,600
+68,900
+18% +$3.39M 0.01% 1075
2018
Q4 		$15.3M Sell
373,700
-17,700
-5% -$663K 0.01% 1252
2018
Q3 		$14.9M Sell
391,400
-608,300
-61% -$26.9M ﹤0.01% 1571
2018
Q2 		$45.2M Buy
999,700
+679,400
+212% +$30.9M 0.02% 743
2018
Q1 		$15.5M Sell
320,300
-17,500
-5% -$976K 0.01% 1419
2017
Q4 		$13.3M Buy
337,800
+233,800
+225% +$8.73M ﹤0.01% 1585
2017
Q3 		$3.23M Sell
104,000
-9,500
-8% -$267K ﹤0.01% 3117
2017
Q2 		$3.1M Sell
113,500
-210,700
-65% -$6.27M ﹤0.01% 3091
2017
Q1 		$11.9M Buy
324,200
+291,700
+898% +$7.35M 0.01% 1468
2016
Q4 		$470K Sell
32,500
-82,200
-72% -$1.44M ﹤0.01% 7127
2016
Q3 		$2.64M Buy
114,700
+101,700
+782% +$1.94M ﹤0.01% 3094
2016
Q2 		$216K Sell
13,000
-3,600
-22% -$72.6K ﹤0.01% 7485
2016
Q1 		$263K Buy
+16,600
New +$295K ﹤0.01% 7479

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's GBT Position: Q4 2022 in Review

Susquehanna International Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 47,540 shares — an estimated $3.24M sold.

Susquehanna International Group first reported a position in GBT in Q3 2015 and held it in 21 quarters. The position peaked at $11.7M in Q2 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Susquehanna International Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 47,540 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.24M.
  • Susquehanna International Group first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 21 quarters.
  • Susquehanna International Group's Global Blood Therapeutics, Inc. position peaked at $11.7M in Q2 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.